The automatic implantable cardioverter-defibrillator in young patients

Jack Kron, R. P. Oliver, S. Norsted, M. J. Silka

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

An international survey identified 40 patients <20 years old who underwent surgical implantation of an automatic implantable cardioverter-defibrillator (AICD). There was a history of aborted sudden cardiac death or sustained ventricular tachycardia in 92.5% of these patients. Twenty-two patients (55%) had structural heart disease; dilated and hypertrophic cardiomyopathy were the most common diagnoses. Eighteen patients (45%) had primary electrical abnormalities including seven with the congenital long QT syndrome. There were no perioperative deaths associated with device implantation. Concomitant drug therapy was administered to 75% of the patients. Defibrillator discharge occurred in 70% of the patients, with 17 patients (42.5%) receiving at least one appropriate shock. There were two sudden and two nonsudden deaths at 28.2 months' median follow-up. Sudden death-free survival rates by life table analysis at 12 and 33 months were 0.94 and 0.88, respectively. Total survival rates at 12 and 33 months were 0.94 and 0.82, respectively. The AICD represents an effective treatment approach for young patients with life-threatening ventricular tachyarrhythmias.

Original languageEnglish (US)
Pages (from-to)896-902
Number of pages7
JournalJournal of the American College of Cardiology
Volume16
Issue number4
StatePublished - 1990
Externally publishedYes

Fingerprint

Implantable Defibrillators
Survival Rate
Long QT Syndrome
Life Tables
Defibrillators
Hypertrophic Cardiomyopathy
Sudden Cardiac Death
Dilated Cardiomyopathy
Ventricular Tachycardia
Sudden Death
Tachycardia
Heart Diseases
Shock
Drug Therapy
Equipment and Supplies

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Kron, J., Oliver, R. P., Norsted, S., & Silka, M. J. (1990). The automatic implantable cardioverter-defibrillator in young patients. Journal of the American College of Cardiology, 16(4), 896-902.

The automatic implantable cardioverter-defibrillator in young patients. / Kron, Jack; Oliver, R. P.; Norsted, S.; Silka, M. J.

In: Journal of the American College of Cardiology, Vol. 16, No. 4, 1990, p. 896-902.

Research output: Contribution to journalArticle

Kron, J, Oliver, RP, Norsted, S & Silka, MJ 1990, 'The automatic implantable cardioverter-defibrillator in young patients', Journal of the American College of Cardiology, vol. 16, no. 4, pp. 896-902.
Kron, Jack ; Oliver, R. P. ; Norsted, S. ; Silka, M. J. / The automatic implantable cardioverter-defibrillator in young patients. In: Journal of the American College of Cardiology. 1990 ; Vol. 16, No. 4. pp. 896-902.
@article{921b8f714a284a96a2c27e7a213892db,
title = "The automatic implantable cardioverter-defibrillator in young patients",
abstract = "An international survey identified 40 patients <20 years old who underwent surgical implantation of an automatic implantable cardioverter-defibrillator (AICD). There was a history of aborted sudden cardiac death or sustained ventricular tachycardia in 92.5{\%} of these patients. Twenty-two patients (55{\%}) had structural heart disease; dilated and hypertrophic cardiomyopathy were the most common diagnoses. Eighteen patients (45{\%}) had primary electrical abnormalities including seven with the congenital long QT syndrome. There were no perioperative deaths associated with device implantation. Concomitant drug therapy was administered to 75{\%} of the patients. Defibrillator discharge occurred in 70{\%} of the patients, with 17 patients (42.5{\%}) receiving at least one appropriate shock. There were two sudden and two nonsudden deaths at 28.2 months' median follow-up. Sudden death-free survival rates by life table analysis at 12 and 33 months were 0.94 and 0.88, respectively. Total survival rates at 12 and 33 months were 0.94 and 0.82, respectively. The AICD represents an effective treatment approach for young patients with life-threatening ventricular tachyarrhythmias.",
author = "Jack Kron and Oliver, {R. P.} and S. Norsted and Silka, {M. J.}",
year = "1990",
language = "English (US)",
volume = "16",
pages = "896--902",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - The automatic implantable cardioverter-defibrillator in young patients

AU - Kron, Jack

AU - Oliver, R. P.

AU - Norsted, S.

AU - Silka, M. J.

PY - 1990

Y1 - 1990

N2 - An international survey identified 40 patients <20 years old who underwent surgical implantation of an automatic implantable cardioverter-defibrillator (AICD). There was a history of aborted sudden cardiac death or sustained ventricular tachycardia in 92.5% of these patients. Twenty-two patients (55%) had structural heart disease; dilated and hypertrophic cardiomyopathy were the most common diagnoses. Eighteen patients (45%) had primary electrical abnormalities including seven with the congenital long QT syndrome. There were no perioperative deaths associated with device implantation. Concomitant drug therapy was administered to 75% of the patients. Defibrillator discharge occurred in 70% of the patients, with 17 patients (42.5%) receiving at least one appropriate shock. There were two sudden and two nonsudden deaths at 28.2 months' median follow-up. Sudden death-free survival rates by life table analysis at 12 and 33 months were 0.94 and 0.88, respectively. Total survival rates at 12 and 33 months were 0.94 and 0.82, respectively. The AICD represents an effective treatment approach for young patients with life-threatening ventricular tachyarrhythmias.

AB - An international survey identified 40 patients <20 years old who underwent surgical implantation of an automatic implantable cardioverter-defibrillator (AICD). There was a history of aborted sudden cardiac death or sustained ventricular tachycardia in 92.5% of these patients. Twenty-two patients (55%) had structural heart disease; dilated and hypertrophic cardiomyopathy were the most common diagnoses. Eighteen patients (45%) had primary electrical abnormalities including seven with the congenital long QT syndrome. There were no perioperative deaths associated with device implantation. Concomitant drug therapy was administered to 75% of the patients. Defibrillator discharge occurred in 70% of the patients, with 17 patients (42.5%) receiving at least one appropriate shock. There were two sudden and two nonsudden deaths at 28.2 months' median follow-up. Sudden death-free survival rates by life table analysis at 12 and 33 months were 0.94 and 0.88, respectively. Total survival rates at 12 and 33 months were 0.94 and 0.82, respectively. The AICD represents an effective treatment approach for young patients with life-threatening ventricular tachyarrhythmias.

UR - http://www.scopus.com/inward/record.url?scp=0025147726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025147726&partnerID=8YFLogxK

M3 - Article

C2 - 2212370

AN - SCOPUS:0025147726

VL - 16

SP - 896

EP - 902

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 4

ER -